Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy
Bagher Farhood, Keywan Mortezaee, Nasser Hashemi Goradel, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 5, pp. 5728-5740
Closed Access | Times Cited: 229

Showing 26-50 of 229 citing articles:

Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Yu Chong, Bo Yang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 6, pp. 397-415
Open Access | Times Cited: 59
Polymeric nanomicelles of curcumin: Potential applications in cancer
Leila Farhoudi, Prashant Kesharwani, Muhammed Majeed, et al.
International Journal of Pharmaceutics (2022) Vol. 617, pp. 121622-121622
Closed Access | Times Cited: 59
The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: A systematic review
Hossein Moutabian, Ruhollah Ghahramani‐Asl, Tohid Mortezazadeh, et al.
BioFactors (2022) Vol. 48, Iss. 3, pp. 597-610
Closed Access | Times Cited: 58
Nano‐Derived Therapeutic Formulations with Curcumin in Inflammation‐Related Diseases
Cristina Quispe, Natália Martins, Maria Letizia Manca, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 57
In Situ Supramolecular Self‐Assembly of Pt(IV) Prodrug to Conquer Cisplatin Resistance
Qian Wang, Xiao Meng, Dianyu Wang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 27
Closed Access | Times Cited: 56
Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress
Mehdi Sanati, Amir R. Afshari, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 287-304
Closed Access | Times Cited: 56
Recent advances in nanogold as a promising nanocarrier for curcumin delivery
Ali Mahmoudi, Prashant Kesharwani, Muhammed Majeed, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 215, pp. 112481-112481
Closed Access | Times Cited: 48
Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry
Elena Obrador, Rosario Salvador‐Palmer, J.I. Villaescusa, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1098-1098
Open Access | Times Cited: 46
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities
Hossein Moutabian, Mehrsa Majdaeen, Ruhollah Ghahramani‐Asl, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 43
The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial
Gholamreza Askari, Amirhossein Sahebkar, Davood Soleimani, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 43
Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases
Niloufar Rahiman, Yuliya V. Markina, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 264-286
Closed Access | Times Cited: 40
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
Bagher Farhood, Masoud Najafi, Tamara Talakesh, et al.
Current Radiopharmaceuticals (2022) Vol. 15, Iss. 4, pp. 332-340
Closed Access | Times Cited: 38
Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Mustafa M. Kadhim, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1624-1639
Closed Access | Times Cited: 34
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
Mandeep Singh, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 33
Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities
Yi Zhang, Ying Huang, Zheng Li, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3585-3585
Open Access | Times Cited: 29
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
Xia Zhou, Xiaokang Wang, Nan Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
siRNA-mediated inhibition of hTERT enhances the effects of curcumin in promoting cell death in precursor-B acute lymphoblastic leukemia cells: an in silico and in vitro study
Muhammad Hossein Ashoub, Ali Afgar, Alireza Farsinejad, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Radioprotection and Enhanced Efficacy by Curcumin-Loaded Chitosan Nanoparticles in Mitigating Radiation-Induced Liver Injury
Rasool Azmoonfar, Masoud Moslehi, Daryoush Shahbazi‐Gahrouei, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151512-151512
Closed Access | Times Cited: 1
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, et al.
Current Clinical Pharmacology (2019) Vol. 14, Iss. 1, pp. 41-53
Closed Access | Times Cited: 73
<p>Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway</p>
Chaofan Hu, Li Wang, Yong Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 3893-3903
Open Access | Times Cited: 64
Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials
Amanda C. Fifi, Cara Axelrod, Partha Chakraborty, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1715-1715
Open Access | Times Cited: 63
Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 60
The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study
Masoud Najafi, Keywan Mortezaee, Mahban Rahimifard, et al.
Life Sciences (2020) Vol. 257, pp. 118051-118051
Closed Access | Times Cited: 58
Curcumin’s Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions
Kevin Zhai, Aranka Brockmüller, Peter Kubatka, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1469-1469
Open Access | Times Cited: 53
Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis
Ting Chen, B. A. Zhuang, Yueqi Huang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2522-2532
Open Access | Times Cited: 50

Scroll to top